Correlation Between Algernon Pharmaceuticals and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and SAB Biotherapeutics, you can compare the effects of market volatilities on Algernon Pharmaceuticals and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and SAB Biotherapeutics.
Diversification Opportunities for Algernon Pharmaceuticals and SAB Biotherapeutics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Algernon and SAB is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Algernon Pharmaceuticals and SAB Biotherapeutics
Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 4.1 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Algernon Pharmaceuticals is 1.37 times less risky than SAB Biotherapeutics. It trades about 0.03 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 303.00 in SAB Biotherapeutics on October 26, 2024 and sell it today you would earn a total of 69.00 from holding SAB Biotherapeutics or generate 22.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 92.86% |
| Values | Daily Returns |
Algernon Pharmaceuticals vs. SAB Biotherapeutics
Performance |
| Timeline |
| Algernon Pharmaceuticals |
| SAB Biotherapeutics |
Algernon Pharmaceuticals and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Algernon Pharmaceuticals and SAB Biotherapeutics
The main advantage of trading using opposite Algernon Pharmaceuticals and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Algernon Pharmaceuticals vs. Cellectis SA | Algernon Pharmaceuticals vs. Biotron Limited | Algernon Pharmaceuticals vs. Resverlogix Corp | Algernon Pharmaceuticals vs. Covalon Technologies |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |